c-Myc 분자 정보
Molecule Name
Myc proto-oncogene protein
분자 별명
c-Myc,MYC,MRTL,bHLHe39
Drug Development Progress
임상 약물 수10
시판 약물 수0
최고 연구 개발 단계Phase 2 Clinical
표적 별명
Class E Basic Helix-Loop-Helix Protein 39，Transcription Factor P64，Proto-Oncogene C-Myc，Myc-Related Translation/Localization Regulatory Factor，Avian Myelocytomatosis Viral Oncogene Homolog，V-Myc Myelocytomatosis Viral Oncogene Homolog，Myc Proto-Oncogene Protein，BHLHE39，C-Myc，MRTL，MYCC，Proto-Oncogene Proteins c-myc，MYC，MYC Proto-Oncogene， BHLH Transcription Factor，V-Myc Avian Myelocytomatosis Viral Oncogene Homolog
분자 배경
The c-Myc tag is a widely used epitope tag in molecular biology for protein expression and detection. Derived from the human c-Myc oncoprotein. This tag is typically fused to target proteins through genetic engineering, allowing researchers to identify, purify, or track the expressed proteins using specific monoclonal antibodies.
c-Myc 제품 목록
Host Species
- Mouse（1）
Conjugate
- Unconjugated（1）
Reactive Species
- Tag（1）
Applications
- ELISA（1）
| 분자 | Cat. No. | Product Name | Host Species | Reactive Species | Applications | 규격 및 가격 |
|---|---|---|---|---|---|---|
| c-Myc | Monoclonal Anti-c-Myc Antibody, Mouse IgG1 (9E10) |  Mouse | Tag | $230.00 100ug |
You Have Viewed 1-1 Of 1 Results
Asset Licensing Opportunity
Resources
임상 약물 정보
| 영어 이름 | 연구 코드 | 연구 개발 단계 | 회사 | 적응증 | 임상 시험 |
|---|---|---|---|---|---|
| XNW-34017 | XNW-34017; XNW34017 | Phase 2 Clinical | Evopoint Biosciences Co Ltd | Neoplasm Metastasis; Solid tumours | 상세 |
| Sepantronium Bromide | YM-155; YM155 monobromide; PC-002 | Phase 2 Clinical | Astellas Pharma Inc | Breast Neoplasms; Burkitt Lymphoma; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Lymphatic Diseases; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Melanoma; Neoplasms; Prostatic Neoplasms; Solid tumours | 상세 |
| OMO-103 | OMO-103; OMO103 | Phase 2 Clinical | Peptomyc SL | Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Osteosarcoma; Pancreatic Neoplasms; Solid tumours | 상세 |
| WP-1066 | WP-1066 | Phase 2 Clinical | Moleculin Biotech Inc | Brain metastases; Brain Neoplasms; Diffuse Intrinsic Pontine Glioma; Glioblastoma; Glioma; Medulloblastoma; Melanoma | 상세 |
| PLX-51107 | PLX-51107 | Phase 1 Clinical | Plexxikon Inc | Graft vs Host Disease; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Myelodysplastic-Myeloproliferative Diseases; Myeloproliferative Disorders; Solid tumours | 상세 |
| SACT-1 | SACT-1 | Phase 1 Clinical | Aptorum Group Llc | Neuroblastoma | 상세 |
| Myrtleciclib | VS 2370; VS2-370 | Phase 1 Clinical | Vichem Chemie | HIV Infections; Neoplasms | 상세 |
| WBC100 | WBC100; WBC-100 | Phase 1 Clinical | Hangzhou Weben Pharmaceutical Co Ltd | Hematologic Neoplasms; Leukemia, Myeloid, Acute; Neoplasms; Solid tumours | 상세 |
| Luxeptinib | CG026806; CG-806; CG’806; CG-026806 | Phase 1 Clinical | Crystalgenomics Inc | Hematologic Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes | 상세 |
| Misetionamide | GP-2250 | Phase 1 Clinical | Geistlich Pharma | Pancreatic Neoplasms | 상세 |
Customer Reviews